Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
2015 · Leukemia · 51 citations
https://doi.org/10.1038/leu.2015.88
K
Karen J. Scott
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
76
Papers
2.2K
Citations
24
h-index
27
i10-index
Karen J. Scott is an academic researcher from University of Leeds. The author has contributed to research in topics: Virus-based gene therapy research & Cancer Research and Treatments & CAR-T cell therapy research. The author has an h-index of 24, co-authored 65 publications.
ORCID: 0000-0002-5790-9579Papers by this author
worksReovirus-Mediated Cytotoxicity and Enhancement of Innate Immune Responses Against Acute Myeloid Leukemia
2012 · BioResearch open access · 31 citations
https://doi.org/10.1089/biores.2012.0205
A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer
2025 · Clinical Cancer Research · 9 citations
https://doi.org/10.1158/1078-0432.ccr-24-2498
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat